Our news

Read through our press releases to follow Signifierʼs latest
news and updates

eXciteOSA Device and SmartPhone

CMS Sets Pricing with New HCPCS Codes for eXciteOSA Therapy, Expanding Access to Innovative Daytime Sleep Apnea Treatment

15th November 2023

Signifier Medical Technologies Announces Upcoming Publication of Randomized Controlled Trial Results Examining High-Intensity (Active) Vs. Low-Intensity (Sham) Neuromuscular Electrical Stimulation in Patients for 6 Weeks

1st November 2023

Neuromuscular Electrical Stimulation as a treatment for obstructive sleep apnea gains traction with a recently announced World Sleep 2023 Congress symposium

25th September 2023

Appointment of new Board

25th August 2023

Signifier Medical Technologies Wins Edison Award for Innovative Sleep Apnea Treatment

20th April 2023

Nasdaq congratulates Signifier Medical Technologies for treating 10,000 patients with eXciteOSA, a daytime therapy for sleep apnea

29th March 2023

Signifier Medical Technologies Reaches a Wider Patient Population with FDA Approval to Remove Dental Contraindications for eXciteOSA

22nd February 2023

Signifier Medical Technologies Announces Participation In Piper Sandler Healthcare Conference

1st December 2022

Signifier Medical Technologies’ eXciteOSA®, the only FDA-authorized daytime therapy for primary snoring and mild obstructive sleep apnea, demonstrates real-world adherence to treatment of over 80%

21st September 2022

Signifier Medical Technologies Announces Publication of Peer-Reviewed Analysis Demonstrating Improvement in Obstructive Sleep Apnea Severity with Neuromuscular Electrical Stimulation

20th July 2022

Signifier Medical Technologies Announces $49MM Purchase of Existing Shares

22nd March 2022

Signifier Medical Technologies is granted HCPCS Codes for eXciteOSA

22nd February 2022

eXciteOSA® Daytime Sleep Apnea Therapy Device Surpasses 50,000 Patient Session Milestone

12th October 2021

Signifier Medical Technologies Raises $35M in Series D Funding Round

27th July 2021

Signifier® Medical Receives Prestigious 2020 GOOD DESIGN Award for Superior Design Excellence

1st March 2021

New Era of Treatment for Sleep Apnea and Snoring with FDA Authorization of eXciteOSA® Device

9th February 2021

Signifier® Medical Technologies Announces Award of UK NHS Supply Chain Tender

22nd December 2020

Signifier® Medical Technologies appoints Alastair Maxwell as Chief Financial Officer

24th November 2020

Signifier® Medical Technologies appoints Jim Hinrichs, former CFO and Director of CareFusion and Alere, to its Board

12th November 2020

Signifier® Medical Technologies appoints Travis Nieman as Managing Director International

8th October 2020

IDEA Design Award 2020 for the World’s First, Daytime Treatment Device Tackling the Root Cause of Sleep-Disordered Breathing

17th September 2020

Signifier® Medical Technologies Closes $10M Series C Funding Round

16th September 2020

Global Webinar on: “Precision Medicine and Non-Invasive Therapies for Mild Obstructive Sleep Apnea”

3rd September 2020

Signifier® Medical Technologies appoints Philip Hess, former President & CEO of Bose Corporation, as Chief Operating Officer

2nd September 2020

Webinar on Precision Medicine and Non-Invasive Therapies for Mild Obstructive Sleep Apnea

30th July 2020

Global Webinar on: “Latest Advances in the Management of Sleep Disordered Breathing”

17th July 2020

Signifier® Medical Technologies Appoints New Senior Member to the USA Organization

17th July 2020

Webinar on Precision Medicine for Obstructive Sleep Apnea and Emerging Technologies

9th June 2020

Webinar on eXciteOSA®: Novel Approach to Treatment of Snoring and Mild OSA

19th May 2020

Webinar on Latest Advances in the Management of Sleep Disordered Breathing

20th April 2020

Signifier Medical Technologies Wins iF Design Award 2020 for Design Excellence for eXciteOSA®

25th February 2020

Signifier® Medical Technologies appoints David Ritscher as Chief Engineer

12th January 2020